Ubat-ubatan manusia Laporan penilaian awam Eropah (EPAR): Mulpleo (dahulunya Lusutrombopag Shionogi), lusutrombopag, Tarikh kebenaran: 18/02/2019, Semakan: 9, Status: Ditarik balik
On 14 April 2026, the European Commission withdrew the marketing authorisation for Mulpleo (lusutrombopag) in the European Union (EU).